| Chelsea Camille Pinnix | |
| Workplaces: | MD Anderson Cancer Center |
| Alma Mater: | University of Maryland, Baltimore County University of Pennsylvania |
| Thesis Title: | Notch1 activation confers transforming properties to primary human melanocytes and promotes human melanoma progression |
| Thesis Url: | http://www.worldcat.org/oclc/244975482 |
| Thesis Year: | 2006 |
Chelsea Camille Pinnix is an American oncologist who is an Associate Professor of Radiation Oncology and Director of the Residency Program at the MD Anderson Cancer Center (MDACC). Having joined the faculty 2012, her research looks to improve the outcomes of patients who suffer from lymphoma.[1] [2] [3]
Pinnix attended the University of Maryland, Baltimore County for her undergraduate degree, where she studied biochemistry. She was a member of the Meyerhoff Scholarship Program.[4] She moved to the University of Pennsylvania for her medical degree, and completed an MD-PhD in 2007.[1] She was awarded a National Institutes of Health Medical Science Scholarship and the NIH Ruth L. Kirschstein National Research Service Award. In 2010 she was supported by the UNCF to complete postdoctoral research at the MDACC.[5]